All articles tagged with #cgm
The article explores the trend of non-diabetics using continuous glucose monitors (CGMs) to track blood sugar, highlighting the potential benefits and drawbacks, including data overload and questionable health advice, while questioning the necessity and impact of such practices for healthy individuals.
The FDA has approved Signos' glucose monitoring system for weight loss, offering an accessible, AI-driven solution that uses continuous glucose monitors to provide real-time data and personalized recommendations, aiming to help Americans manage their weight more effectively and affordably.
The article discusses the rising trend of celebrities and influencers without diabetes wearing continuous glucose monitors (CGMs), raising concerns about their usefulness and potential risks for healthy individuals, as current evidence suggests limited benefits and possible psychological downsides. Experts warn that using CGMs without medical need may lead to unnecessary anxiety and restrictive behaviors, emphasizing the importance of consulting health professionals for personalized advice.
The Trinidad and Tobago government is considering including Continuous Glucose Monitors (CGMs) for children with diabetes in the 2025/2026 budget, following a request from the Diabetes Association of TT. The monitors, which help manage blood sugar levels, are costly but highly beneficial, and the government is exploring funding options to support children with type-one diabetes.
The American Diabetes Association's 2025 Standards of Care introduce new guidelines for diabetes management, including broader use of continuous glucose monitoring (CGM) for type 2 diabetes patients not on insulin, expanded use of GLP-1 receptor agonists for heart and kidney health, and management of metabolic dysfunction-associated liver disease. The guidelines also emphasize the importance of drinking water over sweetened beverages and continuing weight management therapies beyond initial weight loss. Additionally, they recommend screening for psychosocial issues and antibody-based screening for presymptomatic type 1 diabetes in at-risk individuals.
Continuous glucose monitors (CGMs), now available over-the-counter, offer real-time feedback on blood sugar levels, potentially helping individuals, including those with prediabetes, make healthier dietary choices. By providing immediate insights into how foods affect glucose levels, CGMs can motivate users to adjust their eating habits, potentially preventing the progression to type 2 diabetes. These devices, traditionally used by diabetics, are now accessible to a broader audience, offering a proactive approach to managing metabolism and health.
Signos is a startup offering a subscription service that includes a small continuous glucose monitor (CGM) and an app that aims to help users lose weight by tracking their blood sugar. The CGM, which is not intended for diabetes management, sends data to the app to provide personalized insights into how the body responds to specific foods and daily habits like diet, exercise, stress, and sleep. While the platform offers valuable insights, it comes with a high price tag and may not be covered by insurance for non-diabetic users. Users should be mindful of their mental health and consult with a doctor before using the technology.
Continuous glucose monitors (CGMs) with alarm settings that generate too many alerts may lead to alarm fatigue in teenagers with diabetes, causing them to ignore the devices, according to a study presented at the 2023 annual meeting of the Endocrine Society. The study analyzed two weeks of real-time CGM alarm settings from 150 children with diabetes treated at Indiana, and found that alarm settings often varied widely from thresholds recommended by the University of Colorado’s Barbara Davis Center for Diabetes. Experts advise parents and children to be thoughtful about setting their CGM alarm thresholds to be most useful to them.